CIDRAP: Study affirms fractional dosing with yellow fever vaccine
“According to a study … in the Annals of Internal Medicine, fractional dosing of the yellow fever vaccine offers recipients protective antibodies for up to 10 years without a booster dose. The results could inform the use of fractional dosing in preventive vaccination campaigns, and not just outbreak settings. … In related developments, the Nigeria Centre for Disease Control (NCDC) confirmed more cases in an ongoing outbreak in Edo state. … Nigeria is in the midst of the second phase of the largest yellow fever vaccination campaign ever, which aims to reach 26.2 million people to establish a high level of immunity in that country…” (Soucheray, 11/26).